Free Trial

Ayala Pharmaceuticals (ADXS) SEC Filings & 10K Form

Ayala Pharmaceuticals logo
$0.03 -0.08 (-74.77%)
(As of 11/20/2024 ET)

Recent Ayala Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/19/2024
6:50 AM
Ayala Pharmaceuticals (Filer)
Form 8-K/A
04/16/2024
3:11 PM
Ayala Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
3:33 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:33 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:34 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:34 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:30 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:31 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:31 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:32 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/15/2024
3:32 PM
Ayala Pharmaceuticals (Filer)
Form S-8 POS
04/03/2024
4:01 PM
Ayala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:31 PM
Ayala Pharmaceuticals (Filer)
Form NT 10-K
03/29/2024
4:06 PM
Ayala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
6:13 AM
Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:16 AM
Ayala Pharmaceuticals (Filer)
Form DEFM14C
02/20/2024
4:22 PM
Ayala Pharmaceuticals (Filer)
Form PREM14C
02/12/2024
1:16 PM
Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
10:58 AM
Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
Form SC 13D/A
02/12/2024
7:27 AM
Ayala Pharmaceuticals (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13G/A
02/09/2024
4:15 PM
Ayala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
7:51 AM
Ayala Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
8:00 AM
Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
Form SC 13D/A
11/21/2023
8:04 AM
Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
8:00 AM
Ayala Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADXS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners